Research Article

High Risk Infants Follow-Up: A Case Study in Iran

Table 2

Proportion of high risk infants clinically managed over the follow-up period.

Alzahra Hospital (follow-up care) ( = 509)Taleqani Hospital (control) ( = 131)
Admitted/managedConfidence intervalsAdmitted/managedConfidence intervals
%(95%)% (95%)

Cardiac problems 2.20.8, 3.414.58.5, 20.6 ()
Blood pressure00.0, 0.000.0, 0.0
Gastroesophageal reflux21.618.0, 25.27.63.1, 12.2 ()
Bronchopulmonary dysplasia0.00.0, 0.00.00.0, 0.0
Respiratory syncytial virus0.2−0.1, 0.60.00.0, 0.0
Hypothyroidism 9.46.9, 11.918.311.7, 24.9
Osteopenia5.33.4, 7.30.00.0, 0.0
Nutritional assessment 0.00.0, 0.017.611.0, 24.1
Nephrocalcinosis2.20.8, 3.411.55.9, 16.9 ()
Renal tabular acidosis0.00.0, 0.02.3−0.3, 4.9
Anemia19.616.2, 23.13.10.1, 5.9 ()
Developmental dislocation of hip 0.80.0, 1.60.00.0, 0.0
Oral health assessment0.00.0, 0.000.0, 0.0
Autism 0.00.0, 0.000.0, 0.0
Child abuse0.00.0, 0.000.0, 0.0
Sleep disorders 19.315.8, 22.79.24.2, 14.1 ()
Intraventricular hemorrhage0.00.0, 0.00.8−0.1, 2.3
Retinopathy2.81.3, 4.20.8−0.1, 2.3
Neurodevelopmental assessment8.35.9, 10.70.00.0, 0.0
Auditory assessment1.40.4, 2.40.00.0, 0.0

()The difference between proportions is statistically significant.